(Q42983656)

English

A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus

scientific article published on 27 February 2004

Statements

A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus (English)
27 February 2004
964-970

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit